What's new at the pCPA
See all newsWhat we heard about the expansion of our early negotiation process
We asked for your feedback and learned from those insights.
The pCPA’s 2025–26 impact report now available
The pCPA is pleased to share its 2025–26 impact report, Ready for the Road Ahead.
The pCPA helped public drug plans save over $5 billion
The pCPA reached new heights when it comes to savings for public drug plans in 2025–26.
What we've accomplished
$4.4B
Estimated savings for brand-name drugs in 2025–26
$940M
Estimated savings for generic drugs in 2025–26
809
negotiations ended with agreements since 2010
Performance dashboard
Explore the latest negotiation outcomes, timelines, and savings for public drug plans in Canada
Get to know us
We negotiate drug prices with manufacturers on behalf of federal, provincial, and territorial public drug plans to support sustainable coverage and better health outcomes in Canada.
Get to know our processes
We’ve developed different pathways for specific drugs, to support timely negotiations. Explore the pages linked below to learn how our pathways work, get crucial process insights, and access forms and other resources for manufacturers.